抗癌药降税后降价要快马加鞭

2018-06-12 卞广春 健康报网

从5月1日起,28类进口药关税降至零,其中包含了治疗癌症的常用药;对进口抗癌药品,减按3%征收进口环节增值税。但近日记者发现,这些药目前仍是原价出售。有专家说,我国政策的落实有“滞后效应”,一般需要半年到一年的时间。

从5月1日起,28类进口药关税降至零,其中包含了治疗癌症的常用药;对进口抗癌药品,减按3%征收进口环节增值税。但近日记者发现,这些药目前仍是原价出售。有专家说,我国政策的落实有“滞后效应”,一般需要半年到一年的时间。(6月10日《华商报》)

自从28类进口药实施零关税,进口抗癌药品减按3%征收进口环节增值税的消息公布后,公众一致赞许。对比之前,药价能降低近20%。

然而,进口抗癌药降税后的降价过程,远比人们想象的复杂得多。让人纠结的“政策滞后”,一时无解。“零关税”政策后,进口抗癌药何时降价、能降多少,药品供应和销售部门还要等通知。这个通知,涉及财政部门、海关部门、卫生部门、人社部门,又涉及需方、供方、医保方、药企等,需要权衡各方利益。进口抗癌药降税一个月后,降价仍无时间表。

进口抗癌药降税不降价,与网络时代的节奏不符。信息技术为进口抗癌药降税后及时降价提供了可能;行政领域的放管服改革,应当在每个领域、每个角落无障碍推进。进口抗癌药降税,只有让病人看得见、摸得着、体会得到,才有意义。

进口抗癌药降税后及时降价,要有工作效率和时间表。让国外最新、最优的抗癌药,加快步伐进入国内,让病人感受到国外科技对生命救助的价值,感受到税收改革引发的药品低价格,是最现实的便民、利民、为民。有关方面要看到癌症患者及家属与生命赛跑的急切欲望,与民为善,快马加鞭,特事特办,让政策利好尽快降福于广大患者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1314761, encodeId=cc1f1314e61c3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55541, encryptionId=9d4b5554131, topicName=抗癌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425022, encodeId=49ab1425022d5, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323567, encodeId=ddc632356e7e, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Jun 12 13:34:30 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323553, encodeId=493032355361, content=值得期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jun 12 13:30:29 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323541, encodeId=2cf932354159, content=vvv高沟沟壑壑, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0171930782, createdName=为你把脉, createdTime=Tue Jun 12 11:10:41 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-14 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1314761, encodeId=cc1f1314e61c3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55541, encryptionId=9d4b5554131, topicName=抗癌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425022, encodeId=49ab1425022d5, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323567, encodeId=ddc632356e7e, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Jun 12 13:34:30 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323553, encodeId=493032355361, content=值得期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jun 12 13:30:29 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323541, encodeId=2cf932354159, content=vvv高沟沟壑壑, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0171930782, createdName=为你把脉, createdTime=Tue Jun 12 11:10:41 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-14 30397605
  3. [GetPortalCommentsPageByObjectIdResponse(id=1314761, encodeId=cc1f1314e61c3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55541, encryptionId=9d4b5554131, topicName=抗癌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425022, encodeId=49ab1425022d5, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323567, encodeId=ddc632356e7e, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Jun 12 13:34:30 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323553, encodeId=493032355361, content=值得期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jun 12 13:30:29 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323541, encodeId=2cf932354159, content=vvv高沟沟壑壑, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0171930782, createdName=为你把脉, createdTime=Tue Jun 12 11:10:41 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-12 wzb521zf

    一起学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1314761, encodeId=cc1f1314e61c3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55541, encryptionId=9d4b5554131, topicName=抗癌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425022, encodeId=49ab1425022d5, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323567, encodeId=ddc632356e7e, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Jun 12 13:34:30 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323553, encodeId=493032355361, content=值得期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jun 12 13:30:29 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323541, encodeId=2cf932354159, content=vvv高沟沟壑壑, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0171930782, createdName=为你把脉, createdTime=Tue Jun 12 11:10:41 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-12 医者仁心5538

    值得期待

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1314761, encodeId=cc1f1314e61c3, content=<a href='/topic/show?id=9d4b5554131' target=_blank style='color:#2F92EE;'>#抗癌药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55541, encryptionId=9d4b5554131, topicName=抗癌药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425022, encodeId=49ab1425022d5, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Thu Jun 14 01:57:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323567, encodeId=ddc632356e7e, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Jun 12 13:34:30 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323553, encodeId=493032355361, content=值得期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jun 12 13:30:29 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323541, encodeId=2cf932354159, content=vvv高沟沟壑壑, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0171930782, createdName=为你把脉, createdTime=Tue Jun 12 11:10:41 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-12 为你把脉

    vvv高沟沟壑壑

    0

相关资讯

Nat Rev Cancer:抗癌药研发新平台——类器官

过去几年里,“类器官”(organoids)这个名词开始逐渐兴起,相信许多读者也都听说过它的名字。我们知道,类器官可以作为疾病模型协助新药研发,但它的具体应用,恐怕就不是每个人都能说清的了。近日,知名的《Nature Reviews Cancer》上发表了一篇综述,向我们介绍了类器官在癌症研发中的应用。在今天的这篇文章中,我们也将为各位读者整理其中的内容。

国家卫生健康委员会:三措并举降低抗癌药品费用

从5月1日起,我国启动“进口药品零关税”“已纳入医保抗癌药政府集中谈价和采购”“未纳入医保的抗癌药实行医保准入谈判”等3项系列综合措施,降低抗癌药品费用。

柳叶刀:中国抗癌药研发创新和政策改变

近日,《柳叶刀》杂志报告称,中国的抗癌药物领域,正在强调成本控制和癌症药物创新能力。《柳叶刀》报告的核心内容如下:癌症是中国的重大公共卫生问题。根据中国国家癌症登记中心的数据,2015年我国癌症新发病人数约430万人,癌症死亡人数约280万人。中国巨大癌症负担的关键应对措施,迫切需要提高有效抗癌药物的可及性和可获得性。为了减轻癌症患者的经济负担,合理控制昂贵肿瘤药品价格,中国政府已宣布从5月1

5月1日起关税为零 增值税减按3% 抗癌药降价开始了么?

天价抗癌药降价正在开启。5月1日起,进口抗癌药关税为零、增值税减按3%征收等措施正式实施。相对于进口税2%降到零,增值税从17%降到3%,流通、支付环节的成本减幅更加明显。4月27日财政部、海关总署等四部门发布通告称,自2018年5月1日起,增值税一般纳税人生产销售和批发、零售抗癌药品,可选择按照简易办法依照3%征收率计算缴纳增值税。对进口抗癌药品,减按3%征收进口环节增值税。此前,一般纳税人销售

四部门发文明确抗癌药品增值税政策 减按3%征收

据财政部官网显示,昨日,财政部联合海关总署、税务总局、国家药品监督管理局发布《关于抗癌药品增值税政策的通知》。《通知》显示,自2018年5月1日起,对进口抗癌药品,减按3%征收进口环节增值税。

国家财政部:发布第一批降税抗癌药品种清单

近日,国家财政部官网发布了《关于抗癌药品增值税政策的通知》,并公布了第一批抗癌药清单,包含103个抗癌药品制剂以及51个抗癌药品原料药。